Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target?
作者信息
Klann Emily, Rich Shannan, Mai Volker
机构信息
Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
出版信息
Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191.
Abstract
摘要
相似文献
1
Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target?
Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191.
2
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
Clin Infect Dis. 2020 Dec 17;71(10):2669-2678. doi: 10.1093/cid/ciaa709.
3
Microbiota and Coronavirus Disease 2019. Which Came First, the Chicken or the Egg?
Clin Infect Dis. 2021 Jun 15;72(12):2245-2246. doi: 10.1093/cid/ciaa965.
4
Reply to Marcialis et al.
Clin Infect Dis. 2021 Jun 15;72(12):2246-2247. doi: 10.1093/cid/ciaa966.
5
Reply to Klann et al.
Clin Infect Dis. 2021 Jun 15;72(12):2248-2249. doi: 10.1093/cid/ciaa1194.
6
Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Clin Infect Dis. 2021 Jun 15;72(12):e978-e992. doi: 10.1093/cid/ciaa1747.
7
Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features.
Commun Biol. 2021 Apr 13;4(1):480. doi: 10.1038/s42003-021-02036-x.
8
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
Infect Dis Poverty. 2020 Dec 2;9(1):163. doi: 10.1186/s40249-020-00781-5.
9
Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran.
Ann Intern Med. 2020 May 19;172(10):699-701. doi: 10.7326/M20-0696. Epub 2020 Mar 16.
10
COVID-19: review Indigenous peoples' data.
Nature. 2020 Apr;580(7802):185. doi: 10.1038/d41586-020-01032-1.
引用本文的文献
1
Microbiota and COVID-19: Long-term and complex influencing factors.
Front Microbiol. 2022 Aug 12;13:963488. doi: 10.3389/fmicb.2022.963488. eCollection 2022.
2
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources.
Front Pharmacol. 2021 Dec 1;12:758159. doi: 10.3389/fphar.2021.758159. eCollection 2021.
3
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
Int Immunopharmacol. 2020 Dec;89(Pt B):107082. doi: 10.1016/j.intimp.2020.107082. Epub 2020 Oct 10.
Zotero 插件